DISTRIBUTION AND LICENSE AGREEMENTDistribution and License Agreement • July 11th, 2016 • Taxus Cardium Pharmaceuticals Group Inc. • Biological products, (no disgnostic substances) • Delaware
THIS DISTRIBUTION AND LICENSE AGREEMENT (“Agreement”) dated as of June 7, 2016 (“Effective Date”), is entered into between Angionetics Inc., a Delaware corporation having its principal place of business at 11750 Sorrento Valley Rd., Suite 250, San Diego, CA 92121 (“Angionetics”), a wholly-owned subsidiary of Taxus Cardium Pharmaceuticals, Inc. (“Taxus Cardium”) and Pineworld Capital Limited, a corporation having its principal place of business at Flat 01A, 10/F Carnival Commercial Building 18 Java Road, North Point, Hong Kong (“Licensee”).
